Skip to content

Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants

Application of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants and Assessment of Its Benefits Compared to Synchronized Intermittent Mandatory Ventilation (SIMV) With Pressure Support (PS)

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01389882
Enrollment
26
Registered
2011-07-08
Start date
2011-03-31
Completion date
2011-08-31
Last updated
2012-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Preterm

Keywords

mechanical ventilation, diaphragm electrical activity, pressure support

Brief summary

The purpose of this study is to test the hypothesis that neurally adjusted ventilatory assist (NAVA) will allow to lower the ventilator pressure at equivalent fractions of inspiratory oxygen (FiO2) and partial pressure of CO2 of capillary blood in preterm infants in comparison with currently used standard ventilation (synchronized intermittent mandatory ventilation with pressure-support ventilation, SIMV+PSV).

Detailed description

The investigators will apply crossover comparison in preterm infants who received a ventilatory support. In patient whose frequency of mandatory support is under 25, the two ventilatory modes (SIMV+PSV and NAVA) are delivered by the same ventilator (Servo-I; Maquet Critical Care AB, Solna, Sweden) and will set to maintain similar blood gas analysis results. Determination of the type of ventilatory mode used is performed using a cluster randomization. The randomized order of ventilatory mode will be used during total 9 hours; one mode for 4 hours and another mode for 5 hours. To rule out carry-over effects, a 1-hour interval for washout was guaranteed between modes. Recordings will be obtained over a total 8 hours.

Interventions

PROCEDUREneurally adjusted ventilatory assist (NAVA) ventilator mode

Neurally adjusted ventilatory assist (NAVA) utilizes the electrical activity of the diaphragm (EAdi) to trigger and cycle-off breaths, and therefore presents a means of bypassing the ventilator circuit, and the inherent delays with pneumatic triggering. This is a processed signal, which is not artificially influenced by changes in muscle length, chest wall configuration, and/or lung volume. It represents the summation of muscle motor unit recruitment and/or firing rate, and correlates with phrenic nerve activity. In this mode, the amount of support pressure is coupled with the magnitude of the EAdi. The proportion of support pressure to EAdi (NAVA level) is adjustable.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Weeks
Healthy volunteers
No

Inclusion criteria

* preterm infants mechanically ventilated * ventilatory set frequency is under 25 * with informed consent of their parents

Exclusion criteria

* major congenital anomalies * patients without self respiratory effort * use of sedative or anesthetic drugs * grade III or IV intraventricular hemorrhage * phrenic nerve palsy or insufficiency

Design outcomes

Primary

MeasureTime frameDescription
Peak Inspiratory Pressurefour hourspeak inspiratory pressure measured by a ventilator for 4 hours with each ventilator mode

Secondary

MeasureTime frameDescription
Mean Airway Pressurefour hoursmean airway pressure measured by a ventilator for 4 hours with each ventilator mode
Minute Ventilationfour hoursMinute ventilation measured by a ventilator for 4 hours with each ventilator mode
Expiratory Tidal Volumefour hoursExpiratory tidal volume measured by a ventilator for 4 hours with each ventilator mode
Dynamic Compliancefour hoursDynamic Compliance measured by a ventilator for 4 hours with each ventilator mode
Work of Breathingfour hoursWork of breathing of patients measured by a ventilator for 4 hours with each ventilator mode
Peak EAdifour hoursPeak electrical activity of the diaphragm
Fraction of Oxygenfour hoursFraction of oxygen measured by a ventilator for 4 hours with each ventilator mode
Capillary Blood pHfour hoursCapillary blood pH checked immediately after the 4-hour respiratory support with each ventilator mode
Capillary Blood pCO2four hoursCapillary blood pCO2 checked immediately after the 4-hour respiratory support with each ventilator mode
Capillary Blood pO2four hoursCapillary blood pO2 checked immediately after the 4-hour respiratory support with each ventilator mode
Capillary Blood HCO3four hoursCapillary blood HCO3 checked immediately after the 4-hour respiratory support with each ventilator mode

Countries

South Korea

Participant flow

Recruitment details

Participants recruited from a neonatal intensive care unit (NICU) of Seoul National University Hospital, in Seoul, Republic of Korea between March 2011 to July 2011.

Pre-assignment details

26 patients enrolled; 24 assigned to randomization and 2 excluded (1 extubated prior to the study and 1 developed exclusion criteria)

Participants by arm

ArmCount
SN Group
Synchronized intermittent mandatory ventilation (SIMV) with Pressure support (PS) first, then Neurally adjusted ventilatory assist (NAVA)
13
NS Group
NAVA first, then SIMV with PS
11
Total24

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyRespiratory rate > 80/min during study13
Overall StudyWithdrawal by Subject01

Baseline characteristics

CharacteristicSN GroupNS GroupTotal
Age Continuous7 days5 days5 days
Birth Height37.2 cm
STANDARD_DEVIATION 5.9
38.3 cm
STANDARD_DEVIATION 6.7
37.7 cm
STANDARD_DEVIATION 6.2
Birth Weight990 g1630 g1075 g
Capillary Blood HCO324.20 mmol/L
STANDARD_DEVIATION 3.45
21.62 mmol/L
STANDARD_DEVIATION 9.34
23.02 mmol/L
STANDARD_DEVIATION 6.78
Capillary Blood pCO248.83 mmHg
STANDARD_DEVIATION 8.93
44.45 mmHg
STANDARD_DEVIATION 6.34
46.8 mmHg
STANDARD_DEVIATION 8
Capillary Blood pH7.31 pH
STANDARD_DEVIATION 0.04
7.34 pH
STANDARD_DEVIATION 0.06
7.32 pH
STANDARD_DEVIATION 0.05
Capillary Blood pO237.77 mmHg
STANDARD_DEVIATION 7.03
37.00 mmHg
STANDARD_DEVIATION 8.8
37.42 mmHg
STANDARD_DEVIATION 7.72
Gestational Age206 days
STANDARD_DEVIATION 28
212 days
STANDARD_DEVIATION 20
209 days
STANDARD_DEVIATION 24
Region of Enrollment
Korea, Republic of
13 participants11 participants24 participants
Sex: Female, Male
Female
7 Participants0 Participants7 Participants
Sex: Female, Male
Male
6 Participants11 Participants17 Participants
Study Day Body Weight1210 g1530 g1355 g
Study Day Postmenstrual Age220 days
STANDARD_DEVIATION 20
222 days
STANDARD_DEVIATION 15
221 days
STANDARD_DEVIATION 18

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 130 / 11
serious
Total, serious adverse events
0 / 130 / 11

Outcome results

Primary

Peak Inspiratory Pressure

peak inspiratory pressure measured by a ventilator for 4 hours with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSPeak Inspiratory Pressure13.45 cmH2OStandard Deviation 3.44
NAVAPeak Inspiratory Pressure12.45 cmH2OStandard Deviation 2.66
p-value: 0.04395% CI: [0.036, 1.978]Paired t-test
Secondary

Capillary Blood HCO3

Capillary blood HCO3 checked immediately after the 4-hour respiratory support with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSCapillary Blood HCO324.46 mmol/LStandard Deviation 3.95
NAVACapillary Blood HCO324.74 mmol/LStandard Deviation 3.57
p-value: 0.695% CI: [-1.35, 0.802]Paired t-test
Secondary

Capillary Blood pCO2

Capillary blood pCO2 checked immediately after the 4-hour respiratory support with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSCapillary Blood pCO246.75 mmHgStandard Deviation 7.43
NAVACapillary Blood pCO246.64 mmHgStandard Deviation 7.87
p-value: 0.94995% CI: [-3.505, 3.726]Paired t-test
Secondary

Capillary Blood pH

Capillary blood pH checked immediately after the 4-hour respiratory support with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSCapillary Blood pH7.327 pHStandard Deviation 0.051
NAVACapillary Blood pH7.334 pHStandard Deviation 0.046
p-value: 0.51595% CI: [-0.03, 0.016]Paired t-test
Secondary

Capillary Blood pO2

Capillary blood pO2 checked immediately after the 4-hour respiratory support with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSCapillary Blood pO238.89 mmHgStandard Deviation 8.82
NAVACapillary Blood pO237.84 mmHgStandard Deviation 8.51
p-value: 0.70995% CI: [-4.77, 6.875]Paired t-test
Secondary

Dynamic Compliance

Dynamic Compliance measured by a ventilator for 4 hours with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSDynamic Compliance1.70 mL/cmH2OStandard Deviation 0.47
NAVADynamic Compliance1.84 mL/cmH2OStandard Deviation 0.36
p-value: 0.08595% CI: [-0.32, 0.023]Paired t-test
Secondary

Expiratory Tidal Volume

Expiratory tidal volume measured by a ventilator for 4 hours with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSExpiratory Tidal Volume8.73 mL/KgStandard Deviation 2.08
NAVAExpiratory Tidal Volume8.54 mL/KgStandard Deviation 2.24
p-value: 0.60195% CI: [-0.554, 0.931]Paired t-test
Secondary

Fraction of Oxygen

Fraction of oxygen measured by a ventilator for 4 hours with each ventilator mode

Time frame: four hours

ArmMeasureValue (MEDIAN)
SIMV With PSFraction of Oxygen23.33 percentage of concentration
NAVAFraction of Oxygen23.47 percentage of concentration
p-value: 0.31495% CI: [-0.364, 1.749]Wilcoxon signed-rank test
Secondary

Mean Airway Pressure

mean airway pressure measured by a ventilator for 4 hours with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSMean Airway Pressure7.99 cmH2OStandard Deviation 1.33
NAVAMean Airway Pressure8.02 cmH2OStandard Deviation 1.23
p-value: 0.24595% CI: [-0.637, 0.174]Paired t-test
Secondary

Minute Ventilation

Minute ventilation measured by a ventilator for 4 hours with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSMinute Ventilation0.53 L/min/KgStandard Deviation 0.15
NAVAMinute Ventilation0.51 L/min/KgStandard Deviation 0.11
p-value: 0.25795% CI: [-0.02, 0.714]Paired t-test
Secondary

Peak EAdi

Peak electrical activity of the diaphragm

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEAN)Dispersion
SIMV With PSPeak EAdi13.39 uVStandard Deviation 5.68
NAVAPeak EAdi11.70 uVStandard Deviation 5.72
p-value: 0.00995% CI: [0.478, 2.904]Paired t-test, 2-sided
Secondary

Work of Breathing

Work of breathing of patients measured by a ventilator for 4 hours with each ventilator mode

Time frame: four hours

Population: The analysis was per protocol. 19 patients who had completed the study was used for the analysis.

ArmMeasureValue (MEDIAN)
SIMV With PSWork of Breathing11.13 mJ/L
NAVAWork of Breathing8.38 mJ/L
p-value: 0.00295% CI: [1.799, 11.232]Wilcoxon signed-rank test

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026